CUTISS is delighted and proud to have won 2nd place at this year’s “TOP 100 Swiss Startup Award”. CUTISS also won 1st place in the category of TOP biotech, third year in a row now.
Organized by Venturelab and running in its 11th year, the awards are considered to be a benchmark in Switzerland’s startup ecosystem. The jury panel consists of 100 leading investors and startup experts, each of whom selects 10 startups and ranks them by points.
“We are thrilled to win second place at this year’s startup awards,” said CUTISS CEO Daniela Marino. “To have been chosen amongst Switzerland’s 100 most innovative and promising startups is a testament to our team’s hard work to deliver a revolutionary and life-changing medical treatment for millions of people with severe skin injuries. We thank the jury and experts for their recognition of our technology and business.”
This award marks another high for CUTISS in 2021. Earlier this year, two scientific papers were published delivering proof-of-principle for denovoSkin, and the company had also announced the development of the world’s first machine to produce personalized skin grafts.
In 2020 CUTISS won 1st place in the TOP 100 ranking. Prior to that, CUTISS was 6th in 2019, and 5th in 2018.
CUTISS has been ranked 1st in the TOP biotech startups category for three years running.
Further information about this year’s award is available here: https://www.top100startups.swiss/award2021
